Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/10/021487
CTRI/2019/10/021487
Not yet recruiting
Phase 2

A randomized prospective study comparing efficacy and toxicity between concurrent accelerated chemoradiotherapy vs concurrent chemoradiotherapy in locally advanced inoperable head and neck squamous cell cancer

Department of radiotherapy Ipgmer Sskm hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Sponsor
Department of radiotherapy Ipgmer Sskm hospital
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of radiotherapy Ipgmer Sskm hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Age more than 18 yrs and below 70 years
  • •2\. Performance status: Upto ECOG\-2
  • •3\. Histologically \& cytologically proven SC HNC.
  • •4\. Stage: III, IV, Non\-metastatic
  • •5\. Measurable \& evaluable disease without any severe systematic comorbidity or uncontrolled severe haematological abnormality.
  • •6\. Given informed written consent.

Exclusion Criteria

  • •1\. Age: above 70 years.
  • •2\. Performance status: poorer than ECOG \>2\.
  • •3\. Stage: early stage \&metastatic disease
  • •4\. Histologically any other than squamous cell carcinoma.
  • •5\. Previously treated with any type of radiation or chemotherapy: No other
  • •previous or co\-existing malignancy.
  • •6\. Any severe systemic comorbidity or sever

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
A Randomized prospective study comparing efficacy of 0.5% Hyperbaric Levobupivacaine with 0.5% Hyperbaric Bupivacaine for subarachnoid block in Orthopedic lower limb surgeriesHealth Condition 1: W010- Fall on same level from slipping,tripping and stumbling without subsequent striking against objectHealth Condition 2: W183- Other and unspecified fall on samelevelHealth Condition 3: S729- Unspecified fracture of femur
CTRI/2023/01/048768TATA MAIN HOSPITA
Completed
Phase 4
To determine the efficacy and safety of Inj Diclofenac 75mg/ml given intradeltoid with Injection Diclofenac 75mg/3ml given intragluteal in the management of postoperative pain in obese patients.Health Condition 1: null- Post Operative Pain
CTRI/2009/091/000108Troikaa Pharmaceuticals Limited200
Completed
Phase 4
To determine the efficacy and safety of Extended release Paracetamol 650 mg tablet twice a day versus Conventional Paracetamol 500 mg tablet three times a day in the treatment of Osteoarthritis (OA) of knee.Health Condition 1: null- Osteoarthritis (OA) of knee.
CTRI/2010/091/001178Troikaa Pharmaceuticals Limited250
Completed
Not Applicable
A clinical trial to compare the efficacy of pain and comfort scores for pain assessment
CTRI/2017/03/008248Dayanand Medical College and Hospital180
Recruiting
Phase 4
Comparison of efficacy and safety of azathioprine and methotrexate in patients of hand eczema.Health Condition 1: L308- Other specified dermatitis
CTRI/2019/01/017217Postgraduate Institute of Medical Education and Research